「血管内手術の現状と今後の展望」 末梢動脈閉塞，頸動脈に対する血管内手術
スポンサーリンク
概要
- 論文の詳細を見る
In the last decade, the therapeutic strategy for patients with peripheral arterial disease (PAD) has changed markedly after the introduction of endovascular treatment and surgical approaches. In particular, endovascular treatment of iliac occlusive disease is an established treatment modality, although the treatment of infrainguinal lesions remains controversial. The trans-Atlantic Inter-Society Consensus II (TASCII) document of 2007 recommended endovascular treatment in patients with TASCII types A and B lesions and surgical bypass in patients with TASCII types C and D lesions. Most patients with critical limb ischemia (CLI) are in poor general condition, and the goal of revascularization in CLI is not only limb salvage but preservation of life. Currently, bypass surgery is the optimal revascularization procedure for bypass-applicable CLI patients. Improvements in endovascular treatment and expansion of its indication may apply especially to CLI patients who are in poor general condition. Carotid disease is an important cause of stroke and may cause 10-20% of all ischemic strokes. The choice of revascularization strategy in tese cases should be based on the surgical risk profile of the patient and the institution′s expertise. Carotid artery stenting is particularly beneficial for patients at high surgical risk, e.g. surgically inaccessible lesions, radiation-induced carotid stenosis, prior ipsilateral radical neck dissection, and prior carotid endarterectomy. Results of medical treatment continue to improve, but there is still the need for more experience which will aid in establishing treatment strategies for severe carotid disease.
- 日本大学医学会の論文
日本大学医学会 | 論文
- SSPE麻疹ウイルスによる細胞融合能機能解析
- 閉塞性動脈硬化症例おける血管内皮前駆細胞の動態
- 下肢静脈瘤に対する術式の相違による神経障害の検討
- Paclitaxel と Trastuzmab の併用療法が長期間奏効した再発進行乳癌の2例
- 日大外科の手術力 : 2007年度外科学系手術統計